• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Apimeds Pharmaceuticals US, Inc. Common Stock (NY:APUS)

7.250 +2.330 (+47.36%)
Official Closing Price Updated: 8:00 PM EDT, Sep 25, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 37,114,282
Open 8.320
Bid (Size) 6.420 (300)
Ask (Size) 6.500 (200)
Prev. Close 4.920
Today's Range 5.390 - 9.140
52wk Range 1.510 - 59.70
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Top movers in Friday's session ↗
September 25, 2026
Via Chartmill
Unusual volume stocks are being observed in Friday's session. ↗
September 25, 2026
Via Chartmill

Performance

YTD
-56.5%
-56.5%
1 Month
+57.6%
+57.6%
3 Month
-19.4%
-19.4%
6 Month
-62.0%
-62.0%
1 Year
-59.4%
-59.4%

More News

Read More
Top movers analysis in the middle of the day on 2026-09-25: top gainers and losers in today's session. ↗
September 25, 2026
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session. ↗
September 25, 2026
Via Chartmill
News headline image
Emerging Growth DRK GLND APUS GCTK Stocks in the News
September 24, 2026
Via AB Newswire
Topics Artificial Intelligence
News headline image
DarkHorse (NASDAQ: DRK) Strategic Partners Power Up AI Data Center Expansion Across TVA Region
September 24, 2026
Via AB Newswire
Topics Artificial Intelligence
Keep an eye on the top gainers and losers in Thursday's session. ↗
September 24, 2026
Via Chartmill
Discover the most active stocks in Thursday's session. ↗
September 24, 2026
Via Chartmill
TechMediaBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Subsidiary MindWave Signs 12-Month Technology Services Agreement with AQUAE Holdings
September 24, 2026
Via Investor Brand Network
Topics Retirement
The market is filled with gapping stocks in Thursday's session. ↗
September 24, 2026
Via Chartmill
MissionIRNewsBreaks – Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) Engages IBN for Corporate Communications Strategy
September 18, 2026
Via Investor Brand Network
Topics Economy
TechMediaBreaks – MindWave Innovations Inc. (NYSE American: APUS) Centers Digital-Asset Strategy on MindChain and NILA
September 16, 2026
Via Investor Brand Network
InvestorNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Advances Its Vision for Institutional Digital Finance
September 11, 2026
Via Investor Brand Network
MindWave Innovations Builds Toward a New Institutional Blockchain Ecosystem with MindChain and NILA
September 04, 2026
Via Investor Brand Network
TechMediaBreaks – MindWave Innovations Inc.’s (NYSE American: APUS) NILA Gains US Access Ahead of MindChain Launch
September 03, 2026
Via Investor Brand Network
MindWave Innovations Inc. (NYSE American: APUS) Advances an Integrated Digital Finance Ecosystem Through MindChain, NILA and MindWaveDAO
September 03, 2026
Via Investor Brand Network
Topics Economy
What's going on in today's session ↗
September 02, 2026
Via Chartmill
Here are the top movers in Wednesday's session. ↗
September 02, 2026
Via Chartmill
MissionIRNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Targets Institutional RWA Growth with Insured MindChain Layer 2
August 28, 2026
Via Investor Brand Network
MindWave Innovations Inc. (NYSE American: APUS) Is Helping Corporations Hold, Manage, and Generate Risk-Aware Yield on Bitcoin Reserves
August 24, 2026
Via CryptoCurrencyWire
MindWave Innovations Inc. (NYSE American: APUS) Is Helping Corporations Hold, Manage, and Generate Risk-Aware Yield on Bitcoin Reserves
August 24, 2026
Via Investor Brand Network
MissionIRNewsBreaks – MindWave Innovations Inc.’s (NYSE American: APUS) MindChain Brings Enterprise Customization to Ethereum L2
August 20, 2026
Via Investor Brand Network
InvestorNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Puts Institutional Infrastructure at the Center of Its Digital Strategy
August 18, 2026
Via Investor Brand Network
Top movers in Tuesday's pre-market session ↗
August 18, 2026
Via Chartmill
These stocks are moving in today's pre-market session ↗
August 17, 2026
Via Chartmill

Frequently Asked Questions

Is Apimeds Pharmaceuticals US, Inc. Common Stock publicly traded?
Yes, Apimeds Pharmaceuticals US, Inc. Common Stock is publicly traded.
What exchange does Apimeds Pharmaceuticals US, Inc. Common Stock trade on?
Apimeds Pharmaceuticals US, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Apimeds Pharmaceuticals US, Inc. Common Stock?
The ticker symbol for Apimeds Pharmaceuticals US, Inc. Common Stock is APUS on the New York Stock Exchange
What is the current price of Apimeds Pharmaceuticals US, Inc. Common Stock?
The current price of Apimeds Pharmaceuticals US, Inc. Common Stock is 7.250
When was Apimeds Pharmaceuticals US, Inc. Common Stock last traded?
The last trade of Apimeds Pharmaceuticals US, Inc. Common Stock was at 09/25/26 08:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap